New issue of Blood out now featuring MDM4-related bone marrow failure, Pavurutamab in relapsed myeloma, Phenotype-driven analysis of PIEZO1 variants, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies . Have a listen:

🎙️ Just published a new episode of Blood Podcast: IV Iron Risks and Low-Dose AML Gains. Have a listen:

We're thrilled to welcome a new Associate Editor to Blood today! Dr. Omar Abdel-Wahab is the Evnin Family Chair of Molecular Pharmacology at @mskcancercenter.bsky.social where he also serves as Chair of the Molecular Pharmacology Program in the Sloan Kettering Institute. #NewEditor

New issue of Blood out now featuring Freeze-dried platelets for traumatic brain injury, Clonal evolution of NPM1-mutated AML, Iron overload rewires HSC metabolism, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Orca-T for GVHD–free survival and Understanding VEXAS anemia . Have a listen:

New issue of Blood Advances out now featuring Eligibility versus appropriateness in allogeneic HCT, Targeting erythroid cell–derived asparagine inhibits alloimmunization in sickle cell disease, Remission with residuals, but no cure and more. Explore here: ashpublications.org/bloodadvance...

Congratulations to Dr. Andrew Roberts, Editor-in-Chief of Blood, for being awarded the Helen M. Ranney Clinical and Translational Science Medal and Dr. Stella Chou, Blood Editorial Board Member, for earning the William Dameshek Prize.

New issue of Blood RCI out now featuring Red blood cells as sensors of stress in ultramarathons, Emerging concepts in sickle cell disease acute chest syndrome, Iron-refractory iron deficiency anemia and more. Explore here: ashpublications.org/bloodrci/iss...

New issue of Blood out now! Featuring Immune-mediated side effects of cancer immunotherapies, The prevalence and clinical significance of clonal monocytosis, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Treating AML, Before and After Relapse. Have a listen:

We're proud to share that Blood has a JIF of 23.9 and continues its position as the most-cited journal in hematology, with 168,805 total citations in 2025. Blood Advances' JIF is 7.7. With 26,750 citations in 2025, it's among the top ten most cited hematology journals. #JCR2026

New issue of Blood out now featuring Ven-aza and the bone marrow niche, Complement activation in ITP, CD7 CAR T cells for relapsed/refractory AML, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Future Directions in Relapsed and Refractory Large B-cell Lymphoma. Have a listen:

New issue of Blood Global Hematology out now! Featuring Developing nations’ guide to Hodgkin lymphoma, The challenge of treating African children with hydroxyurea, Sickle cell disease: then and now, and more. Explore here: ashpublications.org/bloodglobal/...

Congratulations to our Deputy Editor of Blood, Dr. Jorge Di Paola, on his new role as Executive Vice President and Chief Scientific Officer at @versitiresearch.bsky.social starting in October! Learn more: versiti.org/stories-and-...

New issue of Blood Advances out now featuring Real-world experience with tabelecleucel, Management of relapsed/refractory AL amyloidosis, and more. Explore here: ashpublications.org/bloodadvance...

New issue of Blood out now featuring Predictive markers of glofitamab resistance, CREBBP mutations and lymphomagensis, Arterial thrombosis in hypofibrinogenemia and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Review Series on Clonal Tracking in Hematopoiesis. Have a listen:

A real-world cohort of patients with secondary #erythrocytosis had higher rates of #thrombosis compared with treated PV. Secondary erythrocytosis was associated with a higher prevalence of smoking, obesity, and diabetes mellitus. Read in Blood RCI: ow.ly/qBZZ50Z5bV7

Sepsis-triggered proteolysis of A2 reduces cell surface fibrinolytic activity. A2 proteolysis is associated with microvasculopathic organ dysfunction in humans. Read in Blood VTH: ow.ly/BmOL50Z5cx8

I’m excited to share that my PhD paper is officially out now in @bloodjournals.hematology.org Check out our discovery of how mutant IDH1 but not IDH2 leads to a lineage-specific differentiation block via epigenetic repression of lineage programs! 📄 Paper link below: 👇 doi.org/10.1182/bloo...

New issue of Blood out now featuring CD117-targeted HCT preconditioning in AML and MDS, CSNK1E as a key to unlocking drug persistence in DLBCL, Novel functions of WPB proteins seem to cluster with VWF and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: New Approaches: Marstacimab Therapy and HLH Biomarkers. Have a listen:

New issue of Blood Advances out now featuring CD19 CAR T cells for B-ALL with EMD, Six-year FIX-padua gene therapy in hemophilia B, Popping FVIII concentrates into an updated classification and more. Explore here: ashpublications.org/bloodadvance... #BloodAdvances

Similar ICH rates were observed for patients treated with DOACs and LMWH. No major ICH were observed in patients receiving DOACs. Read in Blood VTH: t.co/CfHrgqudnRv @bloodjournals.hematology.org - thank you for this 🤗

🎙️ Just published a new episode of Blood Podcast: Review Series on Hemophagocytic Lymphohistiocytosis (HLH). Have a listen:

Frontline eltrombopag plus IST is cost-effective compared with IST alone for adults with severe aplastic anemia. Incremental net monetary benefit per patient treated with frontline eltrombopag is ∼$64 000. Read in Blood RCI: ow.ly/hSk250YSvaQ #aplasticanemia #BloodRCI

Harnessing the CD2 axis to broaden & enhance the efficacy of CAR T-cell therapies ft. @albertocarturan.bsky.social, @mat-angelos.bsky.social & @marcoruella.bsky.social (@penncancer.bsky.social) @ruellalab.bsky.social @bloodjournals.hematology.org ashpublications.org/blood/articl...

New issue of Blood out now featuring WM evolution during ibrutinib therapy, Bidirectional relationship for CHIP and IBD, Targeting DHODH in B-ALL and more. Explore here: ashpublications.org/blood/issue/... #BloodJournal #NewIssue

🎙️ Just published a new episode of Blood Podcast: IBD augmentation of CHIP and Platelet mTOR's impact on Cerebral Malaria. Have a listen:

ASH will be at #ASCO26! Visit booth #15032 for #hematology funding opportunities, training programs, leadership pathways, mentorship, career resources, and more. Plus, a meet-and-greet with Dr. Jorge Cortes, Chief Editor of Blood Global Hematology. See you in Chicago! #HemeSky #HemeOnc #OncSky

PACS is a chronic thromboinflammatory disorder driven by persistent endothelial injury, immune dysregulation and coagulation imbalance. The 1-year persistence of coagulation abnormalities supports future surveillance strategies in patients with PACS. ow.ly/TM3a50YV5Og #BloodVTH #PACS

Two multidisciplinary guideline panels prioritized 34 outcomes for 32 research questions related to ALL in AYAs. The prioritized outcomes can inform future primary studies, systematic reviews, and guidelines. Read in Blood Neoplasia: ow.ly/1tJF50YV3e8 #ALL #BloodNeoplasia

New issue of Blood out now featuring Gene therapy for transfusion-dependent thalassemia, Long telomeres and risk of lymphoma, Role of transferrin receptors in hepcidin induction, and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Long-term efficacy and safety of betibeglogene autotemcel for β-thalassemia. Have a listen:

recent @bloodjournals.hematology.org publication on bomedemstat in myelofibrosis! Modest spleen effect but seemed to have some VAF impact! ashpublications.org/bloodadvance...

Genome-wide association studies identified regulatory elements controlling erythropoietin gene expression. Anemia-associated polymorphisms affect known and novel EPO hypoxia response elements. Read in Blood RCI: ow.ly/RzmZ50YStv2

Cobicistat allowed an eightfold reduction in venetoclax while optimizing exposure, demonstrating a cost-effective strategy for AML treatment. Read in Blood Neoplasia: ow.ly/qlzN50YV53A #AML #BloodNeoplasia

New episode of the Blood Podcast is live! Blood editor Dr. James Griffin interviews Drs. Francesco Forconi and Bin Guo on their latest research. Listen now: bloodpodcast.transistor.fm/episodes/2d1... #BloodPodcast #BloodJournal

New issue of Blood Advances out now featuring Finding the genes that fit CPX-351, Investigative reporting on factor VIII whereabouts, Pregnancy after hematopoietic stem cell transplant: an international multicenter study and more. Explore here ➡️ ashpublications.org/bloodadvance...

Get to know the previous Editor-in-Chief of Blood (2019-2024), Dr. Nancy Berliner of @harvardmed.bsky.social and @brighamandwomens.bsky.social: www.linkedin.com/feed/update/...

We're excited to announce our new Associate Editor for Blood VTH, Dr. Scott Cameron of @clevelandclinic.bsky.social. Learn more and join us in congratulating him on this new role: www.linkedin.com/feed/update/...

New issue of #Blood out now featuring Removal of anti-ABO B cells by bispecific antibody, Common variants influence #AML risk and prognosis, a new #howItreat and more. Explore here: ashpublications.org/blood/issue/...

🎙️ Just published a new episode of Blood Podcast: Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab . Have a listen:

Learn more about the 11th Editor-in-Chief of Blood, Dr. Bob Löwenberg! www.linkedin.com/feed/update/...

🩸 New paper in Blood from the Bergmeier Lab! David Paul and David Rocco (co–first authors) identify a new signaling pathway critical for platelet adhesion under arterial shear—advancing insights into platelet function and cardiovascular disease. @bloodjournals.hematology.org

It’s World Hemophilia Day! A recent study in Blood VTH examined social vulnerability, access to care, and outcomes for #hemophilia patients in the United States. Explore the findings: ashpublications.org/bloodvth/art... #WorldHemophiliaDay #WHD2026 #BloodVTH

🎙️ Just published a new episode of Blood Podcast: Real-world availability of CAR T-cell therapies and Implications of Lactoferrin Production during Pregnancy. Have a listen:

We're excited to feature the 10th Editor-in-Chief of Blood, Dr. Cynthia Dunbar, who is also the @ash.hematology.org 2026 President-elect. Learn more about her and her career: www.linkedin.com/feed/update/...